Arcturus Therapeutics Holdings Inc. (ARCT) vs Artiva Biotherapeutics, Inc. (ARTV)
A side-by-side comparison of Arcturus Therapeutics Holdings Inc. and Artiva Biotherapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARCT
Arcturus Therapeutics Holdings Inc.
$13.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ARTV
Artiva Biotherapeutics, Inc.
$7.27HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ARCT vs ARTV
growth of $100 · dividends reinvested · last 2yARCT -38.4% (-21.5%/yr)ARTV -40.6% (-22.9%/yr)ARCT compounded faster over this window
ARCT ARTV
ARCT vs ARTV: by the numbers
- •ARCT is the larger company ($369M vs $355M market cap).
- •Both run net losses; ARTV's is the smaller (0.00% vs -391.90% net margin).
Metrics side by side
Valuation
| Metric | ARCT | ARTV |
|---|---|---|
| P/S ratio | 15.52 | N/A |
| P/B ratio | 2.15 | 1.02 |
Profitability
| Metric | ARCT | ARTV |
|---|---|---|
| Gross margin | 95.50% | 0.00% |
| Operating margin | -111.51% | 0.00% |
| Net margin | -391.90% | 0.00% |
| ROE | -54.29% | -26.14% |
| ROIC | -54.07% | -27.16% |
Growth (annualized)
| Metric | ARCT | ARTV |
|---|---|---|
| Revenue CAGR (5Y) | 22.30% | N/A |
| Total return CAGR (5Y) | -18.73% | N/A |
Go deeper
Dig into the metrics
Arcturus Therapeutics ROEArtiva Biotherapeutics ROEArcturus Therapeutics operating marginArtiva Biotherapeutics operating marginArcturus Therapeutics revenue growthArtiva Biotherapeutics revenue growthArcturus Therapeutics free cash flowArtiva Biotherapeutics free cash flow
Arcturus Therapeutics & Artiva Biotherapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.